Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is the most heterogenous and aggressive subtype of breast cancer. Chemotherapy remains the standard treatment option for patients with TNBC owing to the unavailability of a...

Source: World Journal of Surgical Oncology - June 30, 2023 Category: Cancer & Oncology Authors: Xuanzhao Chen, Zeyan Li, Meihua Liang, Ziyang Zhang, Di Zhu, Biyun Lin, Renyu Zhou and Yuanzhi Lu Tags: Research Source Type: research